503-222-1261 info@crgpdx.com


This is a study to evaluate the safety and efficacy of a study drug vs. placebo in patients with essential hypertension who are not adequately controlled by standard of care.  The study will last approximately 1 year and includes all…

Read More


This is a multicenter, 12-week treatment period study to evaluate the safety, tolerability and efficacy of 3 doses of study drug compared to placebo in patients 18 years of age and older with fasting triglyceride levels between 500 mg/dl and…

Read More


This is a phase 3, multicenter study evaluating the safety, tolerability and efficacy of a single dose of study drug injected in the target knee joint of moderately to severely symptomatic osteoarthritis patients. The study is 26 weeks in duration…

Read More